David Gordon

1.9k total citations
33 papers, 726 citations indexed

About

David Gordon is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, David Gordon has authored 33 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 12 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in David Gordon's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Systemic Lupus Erythematosus Research (11 papers) and T-cell and B-cell Immunology (6 papers). David Gordon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Systemic Lupus Erythematosus Research (11 papers) and T-cell and B-cell Immunology (6 papers). David Gordon collaborates with scholars based in United States, United Kingdom and Germany. David Gordon's co-authors include David A. Roth, C. Molta, Anne E. Hammer, Stefan Lindgren, Pedro Cahn, Graeme Moyle, Trevor R. Scott, James Fettiplace, Herbert Struemper and Henry Zhao and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Gordon

30 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gordon United States 16 239 232 158 143 121 33 726
Kim Nguyen South Africa 20 62 0.3× 272 1.2× 128 0.8× 86 0.6× 119 1.0× 55 1.1k
Milind Nadkar India 14 197 0.8× 151 0.7× 90 0.6× 48 0.3× 104 0.9× 58 660
Marcelo Chen Taiwan 18 141 0.6× 93 0.4× 238 1.5× 23 0.2× 255 2.1× 95 1.1k
José Luis Aguilar United States 15 184 0.8× 124 0.5× 140 0.9× 21 0.1× 48 0.4× 46 1.0k
Nicolás Garcı́a Spain 18 120 0.5× 141 0.6× 152 1.0× 64 0.4× 36 0.3× 45 1.1k
Rebecca Pavlos Australia 15 229 1.0× 168 0.7× 55 0.3× 64 0.4× 79 0.7× 24 882
Jenny Jiang United States 14 132 0.6× 171 0.7× 91 0.6× 117 0.8× 218 1.8× 37 854
Vijayaprakash Suppiah Australia 17 403 1.7× 468 2.0× 155 1.0× 47 0.3× 133 1.1× 49 2.2k
Joaquín Borrás‐Blasco Spain 15 156 0.7× 172 0.7× 36 0.2× 27 0.2× 55 0.5× 61 618
Ping Ji China 16 36 0.2× 183 0.8× 157 1.0× 26 0.2× 185 1.5× 67 709

Countries citing papers authored by David Gordon

Since Specialization
Citations

This map shows the geographic impact of David Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gordon more than expected).

Fields of papers citing papers by David Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gordon. The network helps show where David Gordon may publish in the future.

Co-authorship network of co-authors of David Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of David Gordon. A scholar is included among the top collaborators of David Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gordon. David Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Olorunsaiye, Comfort Z., et al.. (2025). COVID-19 Vaccine Literacy Among Black Pregnant and Postpartum Women in the USA. Journal of Racial and Ethnic Health Disparities.
3.
Roberts, John K., et al.. (2024). Validity Evidence for Using Virtual, Interactive Patient Encounters to Teach and Assess Clinical Reasoning for First-Year Medical Students. Academic Medicine. 100(4). 445–452. 1 indexed citations
4.
Gordon, David, et al.. (2023). Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis. ACR Open Rheumatology. 5(2). 63–70. 7 indexed citations
5.
Gordon, David, et al.. (2021). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study. Clinical Pharmacology Advances and Applications. Volume 13. 123–134. 20 indexed citations
6.
Chen, Rita E., Brittany Smith, John M. Errico, et al.. (2021). Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell Host & Microbe. 29(11). 1634–1648.e5. 8 indexed citations
7.
8.
Sheikh, Saira Z., N. L. Fox, Anne E. Hammer, et al.. (2016). AB0416 Reliability and Safety of A Novel Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus (SLE). Annals of the Rheumatic Diseases. 75. 1048–1049. 1 indexed citations
9.
Doria, Andrea, William Stohl, Andreas Schwarting, et al.. (2016). LB0001 Efficacy and Safety of Subcutaneous Belimumab plus Standard Care in Patients with Systemic Lupus Erythematosus (SLE) with Low Complement and Positive Anti-DSDNA. Annals of the Rheumatic Diseases. 75. 70–71. 2 indexed citations
10.
Bruce, Ian N, Murray B. Urowitz, Ronald van Vollenhoven, et al.. (2015). OP0186 5-Year Organ Damage Accrual and Safety in Patients with Sle Treated with Belimumab Plus Standard of Care. Annals of the Rheumatic Diseases. 74. 142–142. 1 indexed citations
11.
Struemper, Herbert, Jane Gilbert, Matthew E. Barton, et al.. (2015). Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects. Clinical Pharmacology in Drug Development. 5(3). 208–215. 26 indexed citations
12.
Wang, Piwen, et al.. (2014). Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Molecular Nutrition & Food Research. 59(2). 250–261. 56 indexed citations
13.
14.
Lindgren, Stefan & David Gordon. (2011). The doctor we are educating for a future global role in health care. Medical Teacher. 33(7). 551–554. 14 indexed citations
15.
Fitzpatrick, Lorraine A., Christine Dabrowski, David Gordon, et al.. (2011). Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women. Journal of Bone and Mineral Research. 27(2). 255–262. 48 indexed citations
16.
Gordon, David & Stefan Lindgren. (2010). The Global Role of the Doctor in Healthcare. World Medical & Health Policy. 2(1). 19–29. 10 indexed citations
17.
Gordon, David, et al.. (2008). Educating health professionals: the Avicenna project. The Lancet. 371(9617). 966–967. 7 indexed citations
18.
Moyle, Graeme, Edwin DeJesus, Pedro Cahn, et al.. (2005). Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine and Efavirenz for the Treatment of Antiretroviral-Naive HIV-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(4). 417–425. 86 indexed citations
19.
Millward, M.J., Agop Y. Bedikian, Robert M. Conry, et al.. (2004). Randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM): Analysis of long-term survival. Journal of Clinical Oncology. 22(14_suppl). 7505–7505. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Nguyen Breakdown of academic impact, for papers by Milind Nadkar Breakdown of academic impact, for papers by Marcelo Chen Breakdown of academic impact, for papers by José Luis Aguilar Breakdown of academic impact, for papers by Nicolás Garcı́a Breakdown of academic impact, for papers by Rebecca Pavlos Breakdown of academic impact, for papers by Jenny Jiang Breakdown of academic impact, for papers by Vijayaprakash Suppiah Breakdown of academic impact, for papers by Joaquín Borrás‐Blasco Breakdown of academic impact, for papers by Ping Ji
Rankless by CCL
2026